skye pharma

Skyepharma Plans Joint Development With Novartis

SkyePharma PLC announced an agreement with Novartis Pharma AG to jointly develop a new product for the treatment of asthma and chronic obstructive pulmonary disease (COPD). The product will combine Novartis’ novel long-acting bronchodilator QAB149 with two SkyePharma technologies SkyeHaler(TM), a breath-activated multi-dose dry powder inhaler (MDDPI) device, to be marketed by Novartis as the Read more about Skyepharma Plans Joint Development With Novartis[…]

skye pharma

Skyepharma Begins Requip Ocr Clinical

Skyepharma has initiated Phase III clinical trials of the oral controlled release formulation of GlaxoSmithKline‘s Requip (Ropinirole HCl). The new once daily formulation for Parkinson’s disease has been developed utilizing SkyePharma’s Geomatrix technology. Requip OCR is expected to simplify the treatment regime for patients using this drug, thus improving patient convenience and compliance. The company Read more about Skyepharma Begins Requip Ocr Clinical[…]

skye pharma

Approvable Letter Received For Uroxatral

SkyePharma PLC and Sanofi-Synthelabo have received an “approvable letter” from the US FDA for UroXatral (once-daily formulation of alfuzosin) for the symptomatic treatment of benign prostatic hyperplasia. The formulation utilizes SkyePharma’s proprietary oral drug delivery technology, GEOMATRIX. The New Drug Application for UroXatral was submitted in December 2000 in the United States. Michael Ashton, SkyePharma’s Read more about Approvable Letter Received For Uroxatral[…]

skye pharma

Skyepharma Licenses Dermatology Technology

SkyePharma PLC has licensed rights to three topical drug delivery technologies, Crystalip, DermaStick and the ES-Gel system, from Bioglan Pharma PLC. Under the terms of the agreement SkyePharma has paid $9 million in cash and will obtain certain exclusive development and commercial rights in relation to new products from the Crystalip and DermaStick technologies and Read more about Skyepharma Licenses Dermatology Technology[…]

Buy Dragon Pharma Labs of Top Quality

Clenbuterol - Bulk Price

Administration: Oral
Principal Substance: Clenbuterol Hydrochloride
Made by: Dragon Pharma
Unit: 10 x 100 pastilles (40 mcg/tablet)
Price: 10 x $25.00

Masteron 200

Injectable Anabolic Steroid
Main Ingredient: Drostanolone Enanthate
Produced by: Dragon Pharma Labs
Package: 1 X 10 ml (200 mg/ml)

Winstrol Tabs - Cheap Price

Administration: Oral
Active Ingredient: Stanozolol
Produced by: Dragon Pharma LLC
Package: 20 x 100 pills (50 mg/pastille)
Price: 20 x $58.00

Propionat 100

Injectable Anabolic Steroid
Basic Chemical Name: Testosterone Propionate
Made by: Dragon Pharmaceutical
Package: 1 X 10 ml (100 mg/ml)

Deca 300 - Cheap Price

Administration: Injection
Primary Ingredient: Nandrolone Decanoate
Manufacturer: Dragon Pharma Labs
Unit: 20 x 10 mL vial (300 mg/mL)
Price: 20 x $37.00

Clomid - Bulk Price

Administration: Oral
Primary Chemical Name: Clomiphene Citrate
Branded by: Dragon Pharma Labs
Pack: 10 x 100 pastilles (50 mg/tablet)
Price: 10 x $63.00

Cut Long 300

Injectable Steroid for Muscle Growth
Mix of: Drostanolone Enanthate,
Testosterone Enanthate, Trenbolone Enanthate
Manufacturer: Dragon Pharma
10 mL Sterile Multi-dose Vial (300 mg/mL)

Enanthat 250

Injectable Steroid for Muscle Growth
Prime Chemical Name: Testosterone Enanthate
Branded by: Dragon Pharma
10 mL Sterile Multi-dose Vial (250 mg/mL)

EQ 300

Prime Component: Boldenone Undecylenate
Branded by: Dragon Pharma LLC
Unit: 10 mL vial (300 mg/mL)

Winstrol Tabs

Base Chemical Name: Stanozolol
Manufacturer: Dragon Pharmaceutical
Package: 100 pastilles (50 mg/tablet)

Trenbolone 100

Base Ingredient: Trenbolone Acetate
Producer: Dragon Pharma
Package: 10 mL vial (100 mg/mL)

Trenbolone 100

Active Ingredient: Trenbolone Acetate
Branded by: Dragon Pharma LLC
Amount: 10 x 10 mL vial (100 mg/mL)